Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 4, 2012, Pages 308-314

  Wakai, Toshifumi ^a   Shirai, Yoshio ^a   Sakata, Jun ^a   Kameyama, Hitoshi ^a   Nogami, Hitoshi ^a   Iiai, Tsuneo ^a   Ajioka, Yoichi ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Colorectal metastases; Hepatectomy margin; Immunohistochemistry; Intrahepatic micrometastases; Liver neoplasms; Surgical resection

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; COLORECTAL TUMOR; FEMALE; HUMAN; JAPAN; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; MICROMETASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM MICROMETASTASIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84864301427     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-946.
2. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 2005; 23: 8490-8499.
3. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-724.
4. Korita PV, Wakai T, Shirai Y, Sakata J, Takizawa K, Cruz PV, Ajioka Y, Hatakeyama K. Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases. Ann Surg Oncol 2007; 14: 3472-3480.
5. Wakai T, Shirai Y, Sakata J, Valera VA, Korita PV, Akazawa K, Ajioka Y, Hatakeyama K. Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis. Ann Surg Oncol 2008; 15: 2472-2481.
6. Dhir M, Lyden ER, Wang A, Smith LM, Ullrich F, Are C. Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg 2011; 254: 234-242.
7. Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 2009; 16: 2385-2390.
8. Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL. Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 2010; 17: 492-501.
9. Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA. Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg 2012; 255: 237-247.
10. Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirzén F, Cassidy J. Bevacizumab in combination with oxaliplatinbased chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008; 26: 2013-2019.
11. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A AJCC Cancer Staging Manual, 7th edition. Edited by Fleming ID. New York, Springer 2010; pp: 143-164.
12. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
13. Taylor M, Forster J, Langer B, Taylor BR, Greig PD, Mahut C. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 1997; 173: 467-471.
14. Japanese Society for Cancer of the Colon and Rectum: Japanese Classification of Colorectal Carcinoma, 2nd English edition. Edited by Sugihara K. Tokyo, Kanehara 2009; pp: 27-28.
15. Nanko M, Shimada H, Yamaoka H, Tanaka K, Masui H, Matsuo K, Ike H, Oki S, Hara M. Micrometastatic colorectal cancer lesions in the liver. Surg Today 1998; 28: 707-713.
16. Sasaki A, Aramaki M, Kawano K, Yasuda K, Inomata M, Kitano S. Prognostic significance of intrahepatic lymphatic invasion in patients with hepatic resection due to metastases from colorectal carcinoma. Cancer 2002; 95: 105-111.
17. Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H, Kusashio K, Furuya S, Nakajima N. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999; 42: 632-639.
18. Yokoyama N, Shirai Y, Ajioka Y, Nagakura S, Suda T, Hatakeyama K. Immunohistochemically detected hepatic micrometastases predict a high risk of intrahepatic recurrence after resection of colorectal carcinoma liver metastases. Cancer 2002; 94: 1642-1647.